DealAdaptam Therapeutics, a San Sebastián and Barcelona, Spain-based cancer immunotherapy developer, raised €3 million in a pre-seed fundraising round led by Criteria Bio Ventures.
More on Tech.eu →
PRE-SEED
11/16/2025
Vitroscope AS, a Trondheim, Norway-based living tissue drug discovery...
Vitalls, an Abu Dhabi-based hospital vitals monitoring platform, raised...
Primerry, a Mumbai-based pediatric healthcare brand, raised ₹71 million...
CureMeAbroad, a Pune-based medical tourism platform, raised $1.1 million...
Cori Clinical, a London-based clinical trial protocol platform, raised $4...
Atlas Bio, a Basel, Switzerland-based AI in-silico drug testing platform,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
